Epi-Centers for the Prevention of Healthcare-Associated Infections, Antimicrobial Resistance and Adverse Events, 58485 [2015-24673]
Download as PDF
<![CDATA[
Federal Register / Vol. 80, No. 188 / Tuesday, September 29, 2015 / Notices
assistance applications for conformity to
laws, regulations, policies, and
alignment to CDC’s public health goals;
(6) issues grants and cooperative
agreements; (7) provides continuing
surveillance of financial and
administrative aspects of assistancesupported activities to ensure
compliance with HHS and CDC policies;
(8) ensures that grantee performance is
in accordance with assistance
requirements; (9) collects and reports
business management and public health
programmatic data, analyzes and
monitor business management data on
grants and cooperative agreements and
maintains assistance files; and (10)
provides innovative problem-solving
methods in the coordination of
international grants for a wide range of
public health partners in virtually all
major domestic and international health
organizations including resolving issues
with the Department of State.
Delete in its entirety the mission and
function statements for the Procurement
and Grants Office (CAJH).
James Seligman,
Acting Chief Operating Officer, Centers for
Disease Control and Prevention.
John Jernigan, MD, MS,
Division of Healthcare Quality
Promotion, National Center for
Emerging and Zoonotic Infectious
Diseases, Centers for Disease Control
and Prevention, 1600 Clifton RD,
Atlanta, GA 30333. Phone: 404–639–
4245. FAX: 404–639–4046. Email: jqj9@
cdc.gov.
FOR FURTHER INFORMATION CONTACT:
Deborah Loveys, Ph.D., Extramural
Programs Research Office, National
Center for HIV/AIDS, Viral Hepatitis,
STD, and TB Prevention, Centers for
Disease Control and Prevention, U.S.
Department of Health and Human
Services, 1600 Clifton Road, MS E–60,
Atlanta, GA 30333. Telephone: (404)
718–8834. Fax: (404) 718–8848. Email:
hft6@cdc.gov.
ADDRESSES:
Dated: September 22, 2015.
Tiffanee Woodard,
Deputy Branch Chief, Epidemiology Research
and Innovations Branch, Division of
Healthcare Quality Promotion, Centers for
Disease Control and Prevention.
Terrance Perry,
Director, Office of Grants Services, Centers
for Disease Control and Prevention.
[FR Doc. 2015–24673 Filed 9–28–15; 8:45 am]
[FR Doc. 2015–24601 Filed 9–28–15; 8:45 am]
BILLING CODE 4163–18–P
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
[30Day–15–0728]
Epi-Centers for the Prevention of
Healthcare-Associated Infections,
Antimicrobial Resistance and Adverse
Events
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (DHHS).
ACTION: Notice of Domestic Single
Source Competition Expansion
Supplement Funding Opportunity
Announcement (FOA).
AGENCY:
The National Center for
Emerging and Zoonotic Infectious
Diseases (NCEZID) will be providing a
Single Source Competition Supplement
to Harvard Pilgrim Healthcare, an
awardee of the Epi-Centers for the
Prevention of Healthcare-Associated
Infections, Antimicrobial Resistance and
Adverse Events Cooperative Agreement.
The single source supplement will fund
research utilizing proprietary methods
to improve sepsis prevention by better
defining the burden, preventability and
identifying measurers to track progress.
DATES: Effective date is date of
publication in the Federal Register.
asabaliauskas on DSK5VPTVN1PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:54 Sep 28, 2015
Jkt 235001
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencies’ estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
PO 00000
Frm 00024
Fmt 4703
Sfmt 4703
58485
(c) Enhance the quality, utility, and
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Written
comments and/or suggestions regarding
the items contained in this notice
should be directed to the Attention:
CDC Desk Officer, Office of Management
and Budget, Washington, DC 20503 or
by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Proposed Project
National Notifiable Diseases
Surveillance System—Revision—Center
for Surveillance, Epidemiology and
Laboratory Services (CSELS), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The Public Health Services Act (42
U.S.C. 241) authorizes CDC to
disseminate nationally notifiable
condition information. The Nationally
Notifiable Diseases Surveillance System
(NNDSS) is based on data collected at
the state, territorial and local levels as
a result of legislation and regulations in
those jurisdictions that require health
care providers, medical laboratories,
and other entities to submit healthrelated data on reportable conditions to
public health departments. These
reportable conditions, which include
infectious and non-infectious diseases,
vary by jurisdiction depending upon
each jurisdiction’s health priorities and
needs. Infectious disease agents and
environmental hazards often cross
geographical boundaries. Each year, the
Council of State and Territorial Disease
Epidemiologists (CSTE), supported by
CDC, determines which reportable
conditions should be designated
nationally notifiable and voluntarily
submitted to CDC so that information
can be shared across jurisdictional
boundaries and both surveillance and
prevention and control activities can be
coordinated at regional and national
levels.
CDC requests a three-year approval for
a Revision for the National Notifiable
Diseases Surveillance System (NNDSS),
(OMB Control No. 0920–0728,
E:\FR\FM\29SEN1.SGM
29SEN1
]]>Agencies
[Federal Register Volume 80, Number 188 (Tuesday, September 29, 2015)]
[Notices]
[Page 58485]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-24673]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Epi-Centers for the Prevention of Healthcare-Associated
Infections, Antimicrobial Resistance and Adverse Events
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (DHHS).
ACTION: Notice of Domestic Single Source Competition Expansion
Supplement Funding Opportunity Announcement (FOA).
-----------------------------------------------------------------------
SUMMARY: The National Center for Emerging and Zoonotic Infectious
Diseases (NCEZID) will be providing a Single Source Competition
Supplement to Harvard Pilgrim Healthcare, an awardee of the Epi-Centers
for the Prevention of Healthcare-Associated Infections, Antimicrobial
Resistance and Adverse Events Cooperative Agreement. The single source
supplement will fund research utilizing proprietary methods to improve
sepsis prevention by better defining the burden, preventability and
identifying measurers to track progress.
DATES: Effective date is date of publication in the Federal Register.
ADDRESSES: John Jernigan, MD, MS, Division of Healthcare Quality
Promotion, National Center for Emerging and Zoonotic Infectious
Diseases, Centers for Disease Control and Prevention, 1600 Clifton RD,
Atlanta, GA 30333. Phone: 404-639-4245. FAX: 404-639-4046. Email:
jqj9@cdc.gov.
FOR FURTHER INFORMATION CONTACT: Deborah Loveys, Ph.D., Extramural
Programs Research Office, National Center for HIV/AIDS, Viral
Hepatitis, STD, and TB Prevention, Centers for Disease Control and
Prevention, U.S. Department of Health and Human Services, 1600 Clifton
Road, MS E-60, Atlanta, GA 30333. Telephone: (404) 718-8834. Fax: (404)
718-8848. Email: hft6@cdc.gov.
Dated: September 22, 2015.
Tiffanee Woodard,
Deputy Branch Chief, Epidemiology Research and Innovations Branch,
Division of Healthcare Quality Promotion, Centers for Disease Control
and Prevention.
Terrance Perry,
Director, Office of Grants Services, Centers for Disease Control and
Prevention.
[FR Doc. 2015-24673 Filed 9-28-15; 8:45 am]
BILLING CODE 4163-18-P
